Skip to main content

Table 3 Patient operative parameters

From: Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer

 

NACT (%)

n = 110

SURG (%)

n = 267

P value

Mean total operative time

200.4 ± 56.6 mins

182.8 ± 53.5 mins

0.005

Mean operative blood loss

235.1 ± 185.3 ml

197.5 ± 149.9 ml

0.061

Patients with transfusion

10 (9.1%)

44(16.5%)

0.063

Type of resection

  

0.000

Total gastrectomy (via abdomen)

45(40.9%)

66(24.7%)

 

Total gastrectomy (via abd & cht)

2(1.8%)

0(0%)

 

Distal gastrectomy

36(32.7%)

156(58.4%)

 

Proximal gastrectomy (via abd)

24(21.8%)

45(16.9%)

 

Proximal gastrectomy (via abd & cht)

3(2.7%)

0(0.0%)

 

Radical resection

  

0.112

R0

110(100.0%)

260(97.4%)

 

R1 or R2

0(0%)

7(2.6%)

 

Multivisceral resection

16(14.5%)

26(9.7%)

0.177

Reconstruction

   

Total gastrectomy

47(42.7%)

66(24.7%)

1.000

Roux-en-Y

4(8.5%)

6(9.1%)

 

Jejunal interposition with a ρ-pouch

43(91.5%)

60(90.9%)

 

Distal gastrectomy Billroth-I

36(32.7%) 35(97.2%)

156(58.4%) 123(78.8%)

0.074

Billroth-II

1(2.8%)

17(10.9%)

 

Roux-en-Y

0(0.0%)

15(9.6%)

 

Jejunal interposition with a ρ-pouch

0(0.0%)

1(0.6%)

 

Proximal gastrectomy

27(24.5%)

45(16.9%)

0.238

Esophagogastric anastomosis

26(96.3%)

43(95.6%)

 

Jejunal interposition with a ρ-pouch

0(0.0%)

2(4.4%)

 

Others

1(3.7%)

0(0.0%)

 

manual anastomosis

3(2.9%)

1(0.4%)

0.072

Median no. of nodes harvested

32.4 ± 14.0

32.3 ± 13.5

0.963

  1. abd: abdomen; cht: chest